CFP Contact Us - About Us page section

Article

Advertising InformationClick here to view our Media Kit Brett Baxter, Director of Digital Business DevelopmentBrett.Baxter@UBM.com or call 201-984-6271.

PediatricsConsultantLive Submission Inquiries
To submit case reports with accompanying images,
contact: editor@consultantlive.comSubmission Guidelines

PediatricsConsultantLive Reader Feedback
For general questions/comments, contact: editor@consultantlive.com

Editorial Information
For editorial help, contact Susan Kweskin, Editorial Director
Susan.Kweskin@UBM.com or call 203-523-7095.

Advertising InformationClick here to view our Media Kit

Brett Baxter, Director of Digital Business Development
Brett.Baxter@UBM.com or call 201-984-6271.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Related Content
US measles cases reach new record high since eradication declaration in 2000 | Image Credit: © Romolo Tavani - © Romolo Tavani - stock.adobe.com.

US measles cases reach new record high since eradication declaration in 2000

Joshua Fitch, Senior Editor
July 7th 2025
Article

A week into July 2025, the total reported cases in the United States have surpassed the peak of 1274 cases recorded for all 2019.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
FDA approves sebetralstat as first and only on-demand treatment for HAE | Image Credit: Contemporary Pediatrics

FDA approves sebetralstat as first and only on-demand treatment for HAE

Joshua Fitch, Senior Editor
July 7th 2025
Article

Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Key FDA approvals in pediatric health: First half of 2025 | Image Credit: © Postmodern Studio - stock.adobe.com.

Key FDA approvals in pediatric health: First half of 2025

Morgan Ebert, Managing Editor
July 5th 2025
Article

A roundup of the most impactful FDA approvals in pediatric health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.

Advancing pediatric health: Key updates and clinical insights from the first half of 2025 | Image Credit: © terovesalainen - stock.adobe.com.

Advancing pediatric health: Key updates and clinical insights from the first half of 2025

Morgan Ebert, Managing Editor
July 4th 2025
Article

A look back at the most important FDA approvals, clinical research, and expert perspectives shaping pediatric health care in the first half of 2025.

© 2025 MJH Life Sciences

All rights reserved.